The conference is hosted by Davis Polk and BMO Capital Markets.
A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, www.gamida-cell.com, and will be available for at least 30 days following the event.
About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion technology to develop product candidates designed to address the limitations of cell therapies. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190422005095/en/
Contacts
Jaren Irene Madden
jaren@gamida-cell.com
1-617-892-9084
Media Inquiries
Krystle Gibbs
krystle@tenbridgecommunications.com
508-479-6358
Source: Gamida Cell Ltd.
View this news release online at:
http://www.businesswire.com/news/home/20190422005095/en
